XXII

22nd Century Group, Inc. [XXII] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

XXII Stock Summary

Top XXII Correlated Resources

XXII


Top 10 Correlated ETFs

XXII


Top 10 Correlated Stocks

XXII


In the News

09:15 07 Dec 2022 XXII

3 Best Marijuana Stocks to Buy in December

All three are pursuing strategies that are working and will work even better in the long term.

08:19 07 Dec 2022 XXII

22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences

BUFFALO, N.Y., Nov. 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company will be participating in the following investor conferences:

10:53 07 Dec 2022 XXII

22nd Century Group, Inc. (XXII) Q3 2022 Earnings Call Transcript

22nd Century Group, Inc. (NASDAQ:XXII ) Q3 2022 Earnings Conference Call November 8, 2022 10:00 AM ET Company Participants Mei Kuo - Director of Communications and Investor Relations James Mish - Chief Executive Officer John Miller - President, Tobacco Business Hugh Kinsman - Chief Financial Officer Conference Call Participants Vivien Azer - Cowen & Company Aaron Grey - Alliance Global Partners Brian Wright - Roth Capital Partners Jim McIlree - Dawson James Alex Fuhrman - Craig Hallum Operator Welcome to the 22nd Century Group's Third Quarter 2022 Conference Call and Webcast. At this time all participants' have been placed in a listen-only mode and the floor will be opened for your questions following management's prepared remarks.

08:17 07 Dec 2022 XXII

22nd Century Group (XXII) Reports Q3 Loss, Lags Revenue Estimates

22nd Century (XXII) delivered earnings and revenue surprises of -20% and 1.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

09:15 07 Dec 2022 XXII

22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022

BUFFALO, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, will release third quarter 2022 financial results on Tuesday, November 8, 2022, at 6:00 a.m. ET. In conjunction with the news release, 22nd Century Group will host a conference call at 10:00 a.m. ET on the same day.

09:20 07 Dec 2022 XXII

22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26

BUFFALO, N.Y., Oct. 18, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that James A. Mish, chief executive officer, will present at the LD Micro Main Event Investor Conference in Los Angeles, California on Wednesday, October 26, 2022 at 11:00 a.m. PT.

01:29 07 Dec 2022 XXII

Best Penny Stocks To Buy Now That CPI Is Out? 5 For Your Watch List

Best penny stocks to buy right now? The post Best Penny Stocks To Buy Now That CPI Is Out?

03:43 07 Dec 2022 XXII

22nd Century Group, Inc. (XXII) CEO Jim Mish on Q2 2022 Results - Earnings Call Transcript

22nd Century Group, Inc. (NASDAQ:XXII ) Q2 2022 Earnings Conference Call August 9, 2022 10:00 AM ET Company Participants Joe Schepers - Vice President of Communications & Investor Relations Jim Mish - Chief Executive Officer John Miller - President of Tobacco Business Hugh Kinsman - Chief Financial Officer Conference Call Participants Vivien Azer - Cowen Aaron Grey - Alliance Global Partners Brian Wright - Roth Capital Partners Jim McIlree - Dawson James Alex Berman - Craig-Hallum Capital Group Operator Welcome to the 22nd Century Group's Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode and the floor will be opened for questions following management's prepared remarks.

08:17 07 Dec 2022 XXII

22nd Century Group (XXII) Reports Q2 Loss, Tops Revenue Estimates

22nd Century (XXII) delivered earnings and revenue surprises of -20% and 18.83%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

01:32 07 Dec 2022 XXII

22nd Century (XXII) Upgraded to Strong Buy: Here's What You Should Know

22nd Century (XXII) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

XXII Financial details

Company Rating
Neutral
Market Cap
251.9M
Income
-47.48M
Revenue
50.87M
Book val./share
0.58
Cash/share
0.21
Dividend
-
Dividend %
-
Employees
76
Optionable
No
Shortable
Yes
Earnings
27 Feb 2023
P/E
-4.85
Forward P/E
-7.33
PEG
-0.57
P/S
4.54
P/B
1.91
P/C
5.24
P/FCF
-5.7
Quick Ratio
2.61
Current Ratio
3.45
Debt / Equity
0.01
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.26
EPS next Y
-0.15
EPS next Q
-0.02
EPS this Y
50%
EPS next Y
-44.23%
EPS next 5Y
-44.23%
EPS last 5Y
10.07%
Revenue last 5Y
13.27%
Revenue Q/Q
33.89%
EPS Q/Q
-
-
-
-
-
SMA20
-8.73%
SMA50
8.49%
SMA100
-42.79%
Inst Own
24.4%
Inst Trans
-1.63%
ROA
-33%
ROE
-55%
ROC
-0.35%
Gross Margin
5%
Oper. Margin
-84%
Profit Margin
-93%
Payout
-
Shs Outstand
215.3M
Shs Float
212.75M
-
-
-
-
Target Price
5.5
52W Range
0.85-3.52
52W High
-
52W Low
-
RSI
44.26
Rel Volume
0.38
Avg Volume
1.72M
Volume
661.14K
Perf Week
-6.78%
Perf Month
-6.78%
Perf Quarter
-40.54%
Perf Half Y
-40.54%
-
-
-
-
Beta
1.88901
-
-
Volatility
0.03%, 0.08%
Prev Close
-2.65%
Price
1.1
Change
-4.35%

XXII Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
0.160.210.210.20.2
Net income per share
-0.13-0.06-0.21-0.14-0.21
Operating cash flow per share
-0.12-0.14-0.12-0.11-0.15
Free cash flow per share
-0.14-0.15-0.12-0.12-0.15
Cash per share
0.620.450.310.160.31
Book value per share
0.750.570.490.320.42
Tangible book value per share
0.670.50.430.260.37
Share holders equity per share
0.750.570.490.320.42
Interest debt per share
00.010.010.010.02
Market cap
355.08M289.62M123.62M347.03M318.66M
Enterprise value
351.42M290.55M124.22M346.79M319.66M
P/E ratio
-27.25-36.35-4.65-17.61-9.77
Price to sales ratio
21.3910.964.7912.3510.3
POCF ratio
-29.42-16.23-8.47-22.22-13.95
PFCF ratio
-25.96-15.28-7.88-21.5-13.33
P/B Ratio
4.714.061.997.874.82
PTB ratio
4.714.061.997.874.82
EV to sales
21.1710.994.8112.3410.33
Enterprise value over EBITDA
-29.16-43.93-4.95-19.19-10.31
EV to operating cash flow
-29.12-16.28-8.52-22.2-14
EV to free cash flow
-25.7-15.33-7.92-21.48-13.37
Earnings yield
-0.04-0.03-0.21-0.06-0.1
Free cash flow yield
-0.04-0.07-0.13-0.05-0.08
Debt to equity
00.01000.02
Debt to assets
0.050.080.10.150.13
Net debt to EBITDA
0.3-0.14-0.020.01-0.03
Current ratio
15.6811.837.393.866.45
Interest coverage
-456.98-2.2K-417.98-266.43-489.86
Income quality
0.932.240.550.790.7
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.430.2900.530
Research and developement to revenue
0.20.570.310.150.11
Intangibles to total assets
0.090.130.120.160.1
Capex to operating cash flow
0.130.060.070.030.05
Capex to revenue
-0.1-0.04-0.04-0.02-0.03
Capex to depreciation
-1.7-0.82-0.77-0.34-0.7
Stock based compensation to revenue
0.060.120.140.060.13
Graham number
1.470.911.531.011.41
ROIC
-0.18-0.33-0.37-0.43-0.42
Return on tangible assets
-0.18-0.12-0.44-0.45-0.48
Graham Net
0.60.420.270.130.26
Working capital
63.31M56.02M36.96M21M45.96M
Tangible asset value
67.99M61.53M53.56M35.9M58.16M
Net current asset value
63.31M55.18M35.84M20.76M44.51M
Invested capital
00.020.020.020.04
Average receivables
1.56M1.52M1.51M2.16M1.37M
Average payables
1.6M1.85M1.56M1.12M1.64M
Average inventory
2.66M2.54M2.15M2.03M2.46M
Days sales outstanding
21.0412.0312.2528.036.9
Days payables outstanding
43.8836.8228.2415.2727.46
Days of inventory on hand
69.2243.5232.0427.8336.41
Receivables turnover
17.3430.3329.813.0252.9
Payables turnover
8.329.9112.9223.913.29
Inventory turnover
5.278.3911.3913.1110.02
ROE
-0.17-0.11-0.43-0.45-0.49
Capex per share
-0.02-0.01-0.010-0.01

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
0.050.050.060.080.09
Net income per share
-0.06-0.09-0.05-0.06-0.06
Operating cash flow per share
-0.04-0.03-0.05-0.06-0.06
Free cash flow per share
-0.04-0.03-0.05-0.07-0.07
Cash per share
0.340.30.240.140.21
Book value per share
0.490.410.360.550.58
Tangible book value per share
0.440.360.310.270.33
Share holders equity per share
0.490.410.360.550.58
Interest debt per share
0.010.010.010.050.04
Market cap
481.65M502.95M378.52M387.67M194.85M
Enterprise value
482.29M503.95M378.63M394.02M201.05M
P/E ratio
-12.76-9-10.61-8.43-3.72
Price to sales ratio
61.6663.1941.8526.7810.05
POCF ratio
-81.13-108.58-47.75-32.79-15.11
PFCF ratio
-79.23-100.71-45.65-30.07-13.57
P/B Ratio
6.17.616.533.91.61
PTB ratio
6.17.616.533.91.61
EV to sales
61.7463.3141.8627.2210.37
Enterprise value over EBITDA
-53.53-37.2-44.59-36.9-14.57
EV to operating cash flow
-81.23-108.8-47.76-33.32-15.59
EV to free cash flow
-79.34-100.91-45.67-30.56-14
Earnings yield
-0.02-0.03-0.02-0.03-0.07
Free cash flow yield
-0.01-0.01-0.02-0.03-0.07
Debt to equity
0.010.020.020.020.01
Debt to assets
0.090.130.130.170.15
Net debt to EBITDA
-0.07-0.07-0.01-0.59-0.45
Current ratio
8.936.456.262.473.45
Interest coverage
-329.09-645.14-1.63K-136.05-103.16
Income quality
0.630.330.891.030.98
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.110.120.110.130.07
Intangibles to total assets
0.090.10.120.420.37
Capex to operating cash flow
0.020.080.050.090.11
Capex to revenue
-0.02-0.05-0.04-0.07-0.08
Capex to depreciation
-0.35-0.93-0.86-1.44-1.08
Stock based compensation to revenue
0.140.140.130.080.12
Graham number
0.80.890.660.880.9
ROIC
-0.1-0.13-0.14-0.1-0.12
Return on tangible assets
-0.12-0.21-0.15-0.17-0.15
Graham Net
0.310.250.20.080.15
Working capital
55.21M45.96M37.8M26.57M45.74M
Tangible asset value
70.98M58.16M50.04M49.53M69M
Net current asset value
54.73M44.51M36.47M24.66M43.31M
Invested capital
0.030.040.030.090.07
Average receivables
2.92M2.62M2.94M4.66M4.8M
Average payables
2.98M3.35M3.02M4.52M5.16M
Average inventory
6.36M6.45M6.89M10.02M11.14M
Days sales outstanding
13.586.6112.1428.9423
Days payables outstanding
17.6425.8215.8529.9627.76
Days of inventory on hand
33.0434.2439.3466.3758.82
Receivables turnover
6.6313.617.413.113.91
Payables turnover
5.13.495.6833.24
Inventory turnover
2.722.632.291.361.53
ROE
-0.12-0.21-0.15-0.12-0.11
Capex per share
000-0.01-0.01

XXII Frequently Asked Questions

What is 22nd Century Group, Inc. stock symbol ?

22nd Century Group, Inc. is a US stock , located in Williamsville of New york and trading under the symbol XXII

Is 22nd Century Group, Inc. buy or a sell ?

2 stock analysts have 2 predictions with a medium analyst target price of $5.5. The lowest prediction is $5 and the highest is $6

What is XXII stock prediction ?

What is 22nd Century Group, Inc. stock quote today ?

22nd Century Group, Inc. stock price is $1.1 today.

Is 22nd Century Group, Inc. stock public?

Yes, 22nd Century Group, Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap